TABLE 1.
Sex | Clinical form | TOTAL | ||
---|---|---|---|---|
Lepromatous | Borderline | P-value (clinical form) | ||
Male | 72 (92.30%) | 6 (7.70%) | (p<0.01) | 78 |
Female | 18 (81.80%) | 4 (18.20%) | (p<0.01) | 22 |
P-value (sex) | (p>0.05) | (p>0.05) | ||
Total | 90 (90.00%) | 10 (10.00%) | 100 |
Sex | Clinical form | TOTAL | ||
---|---|---|---|---|
Lepromatous | Borderline | P-value (clinical form) | ||
Male | 72 (92.30%) | 6 (7.70%) | (p<0.01) | 78 |
Female | 18 (81.80%) | 4 (18.20%) | (p<0.01) | 22 |
P-value (sex) | (p>0.05) | (p>0.05) | ||
Total | 90 (90.00%) | 10 (10.00%) | 100 |